Optomed
4.185 EUR 0%Optomed is a medical technology company. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that is resold under different brands. The company operates worldwide, with the largest presence in the Nordic market. The customers consist of research institutes and hospitals. Optomed is headquartered in Oulu.
Log in to see the recommendation and risk by Inderes
Analyst
Latest videos
Financial calendar
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Skandinaviska Enskilda Banken Ab (publ) Helsinki Branch | 8.2 % | 8.2 % |
OP-Finland Small Cap | 7.9 % | 7.9 % |
Premium
This content is for our Premium customers only.
Insider Transactions
Insider | Date | Total value |
---|---|---|
Juho-pekka Himberg | 05.03.2024 | 114,114EUR |
Reijo Tauriainen | 06.05.2022 | 11,365EUR |
Premium
This content is for our Premium customers only.
Forum updates
Income statement
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Revenue | 13.0 | 14.9 | 14.7 | 15.1 | 16.5 | 23.3 | 29.8 | 37.8 |
growth-% | -13.1 % | 14.1 % | -1.3 % | 3.0 % | 9.2 % | 41.2 % | 28.1 % | 26.8 % |
EBITDA | -0.7 | -2.0 | -2.0 | -1.8 | -2.5 | -0.1 | 2.9 | 6.6 |
EBIT (adj.) | -2.9 | -4.8 | -5.1 | -3.7 | -4.8 | -2.6 | 0.3 | 3.9 |
EBIT | -2.9 | -4.8 | -5.1 | -4.0 | -4.8 | -2.6 | 0.3 | 3.9 |
Profit before taxes | -3.2 | -4.3 | -5.6 | -4.5 | -4.6 | -3.0 | -0.1 | 3.6 |
Net income | -3.2 | -4.2 | -5.5 | -4.4 | -4.6 | -3.0 | -0.1 | 3.6 |
EPS (adj.) | -0.24 | -0.31 | -0.38 | -0.25 | -0.26 | -0.17 | -0.01 | 0.20 |
growth-% | ||||||||
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
Dividend ratio | 50.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
EBITDA-% | -5.6 % | -13.5 % | -13.3 % | -11.8 % | -15.2 % | -0.5 % | 9.8 % | 17.4 % |
EBIT-% (adj.) | -22.3 % | -32.2 % | -34.8 % | -24.3 % | -29.0 % | -11.2 % | 0.9 % | 10.4 % |
EBIT-% | -22.3 % | -32.2 % | -34.8 % | -26.3 % | -29.0 % | -11.2 % | 0.9 % | 10.4 % |
ROE | -14.9 % | -22.9 % | -29.3 % | -21.8 % | -25.6 % | -20.8 % | -1.0 % | 24.6 % |
ROI | -9.8 % | -18.9 % | -20.5 % | -15.5 % | -20.5 % | -11.7 % | 1.6 % | 16.6 % |
Login required
This content is only available for logged in users
Valuation
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Share price (EUR) | 7.22 | 9.80 | 3.75 | 3.72 | 4.19 | 4.19 | 4.19 | 4.19 |
Shares | 13.3 | 13.6 | 16.2 | 17.8 | 17.8 | 17.8 | 17.8 | 17.8 |
Market cap | 95.8 | 133.1 | 60.5 | 66.0 | 74.4 | 74.4 | 74.4 | 74.4 |
Enterprise value | 91.7 | 133.3 | 57.3 | 62.3 | 75.4 | 79.1 | 79.9 | 77.9 |
EV/S | 7.0 | 9.0 | 3.9 | 4.1 | 4.6 | 3.4 | 2.7 | 2.1 |
EV/EBITDA | - | - | - | - | - | - | 27.4 | 11.9 |
EV/EBIT (adj.) | - | - | - | - | - | - | 303.9 | 19.7 |
EV/EBIT | - | - | - | - | - | - | 303.9 | 19.7 |
P/E (adj.) | - | - | - | - | - | - | - | 20.9 |
P/E | - | - | - | - | - | - | - | 20.9 |
P/B | 4.8 | 7.8 | 3.0 | 3.2 | 4.7 | 5.8 | 5.9 | 4.6 |
P/S | 7.4 | 9.0 | 4.1 | 4.4 | 4.5 | 3.2 | 2.5 | 2.0 |
Dividend yield | 2.4 % | |||||||
Equity ratio | 64.6 % | 58.8 % | 65.0 % | 70.0 % | 57.5 % | 44.7 % | 40.0 % | 45.0 % |
Gearing ratio | -20.4 % | 1.2 % | -16.0 % | -18.5 % | 6.6 % | 36.6 % | 43.7 % | 21.4 % |
Login required
This content is only available for logged in users
Quarter data
Q1/23 | Q2/23 | Q3/23 | Q4/23 | 2023 | Q1/24e | Q2/24e | Q3/24e | Q4/24e | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 3.5 | 3.7 | 4.2 | 3.7 | 15.1 | 3.7 | 4.0 | 4.1 | 4.8 |
EBITDA | -0.5 | -0.5 | -0.0 | -0.8 | -1.8 | -0.5 | -0.4 | -0.8 | -0.8 |
EBIT | -1.0 | -1.0 | -0.6 | -1.3 | -4.0 | -1.1 | -1.0 | -1.3 | -1.4 |
Profit before taxes | -1.2 | -1.3 | -0.5 | -1.5 | -4.5 | -1.0 | -0.9 | -1.3 | -1.4 |
Net income | -1.2 | -1.3 | -0.4 | -1.5 | -4.4 | -1.0 | -0.9 | -1.3 | -1.4 |
Login required
This content is only available for logged in users
Optomed Oyj: Optomed Plc - Managers' transactions - Himberg
Optomed Oyj: Optomed Plc - Managers' transactions - Knuutti
Join Inderes community
Don't miss out - create an account and get all the possible benefits